• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.10% Nasdaq Down1.82%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    5.16 Down 0.83(13.86%) 4:00PM EST
    |After Hours : 5.18 Up 0.02 (0.39%) 7:09PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development20,971  17,234  16,113  15,605  
    Selling General and Administrative16,672  9,330  7,427  6,018  
    Non Recurring8  26  10  11  
    Others395  353  508  364  
    Total Operating Expenses38,046  26,943  24,058  21,998  
    Operating Income or Loss (38,046) (26,943) (24,058) (21,998)
    Income from Continuing Operations
    Total Other Income/Expenses Net262  148  142  43  
    Earnings Before Interest And Taxes(37,784)(26,795)(23,916)(21,955)
    Interest Expense17  338  372  378  
    Income Before Tax(37,801)(27,133)(24,288)(22,333)
    Income Tax Expense -   -   -  (1,113)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(37,801)(27,133)(24,288)(21,220)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (37,801) (27,133) (24,288) (21,220)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (37,801) (27,133) (24,288) (21,220)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.